应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VRTX 福泰制药
交易中 03-28 15:35:30 EDT
418.71
+1.39
+0.33%
最高
420.67
最低
415.06
成交量
63.88万
今开
419.48
昨收
417.32
日振幅
1.34%
总市值
1,082亿
流通市值
1,078亿
总股本
2.58亿
成交额
2.68亿
换手率
0.25%
流通股本
2.57亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
回到街头:Web3数字时尚嘉年华,五大亮点燃爆香港
财华社 · 03-26 19:26
回到街头:Web3数字时尚嘉年华,五大亮点燃爆香港
Vertex, Inc.2023财年实现净利润-13.09百万美元,同比减少6.42%
自选股智能写手 · 03-08
Vertex, Inc.2023财年实现净利润-13.09百万美元,同比减少6.42%
Vertex, Inc.盘中异动 早盘股价大跌5.99%
自选股智能写手 · 03-04
Vertex, Inc.盘中异动 早盘股价大跌5.99%
Vertex, Inc.盘中异动 早盘急速上涨29.92%报33.00美元
自选股智能写手 · 02-29
Vertex, Inc.盘中异动 早盘急速上涨29.92%报33.00美元
BUZZ-Vertex Energy 因第四季度亏损跌至三年来最低点
Reuters · 02-28
BUZZ-Vertex Energy 因第四季度亏损跌至三年来最低点
Vertex Inc 预计每股收益 11 美分 - 财报前瞻
Reuters · 02-27
Vertex Inc 预计每股收益 11 美分 - 财报前瞻
Vertex Energy Inc 预计每股亏损 14 美分 - 财报前瞻
Reuters · 02-26
Vertex Energy Inc 预计每股亏损 14 美分 - 财报前瞻
分析-2023 年美国新药价格同比上涨 35
Reuters · 02-23
分析-2023 年美国新药价格同比上涨 35
Vertex Protocol——有望成为永续合约DEX龙头
PentaLab · 02-23
Vertex Protocol——有望成为永续合约DEX龙头
Google Cloud宣布推出Gemma 可于Vertex AI上使用
阿斯达克财经 · 02-22
Google Cloud宣布推出Gemma 可于Vertex AI上使用
BUZZ-CRISPR Therapeutics 因季度利润向好而上涨
Reuters · 02-21
BUZZ-CRISPR Therapeutics 因季度利润向好而上涨
福泰制药2023财年实现净利润36.20亿美元,同比增加8.97%
自选股智能写手 · 02-06
福泰制药2023财年实现净利润36.20亿美元,同比增加8.97%
美国研究综述-空气化工产品公司 , Hubspot 和麦当劳
Reuters · 02-06
美国研究综述-空气化工产品公司 , Hubspot 和麦当劳
更新版 1-Vertex公司的三联CF疗法达到后期试验的主要目标
Reuters · 02-06
更新版 1-Vertex公司的三联CF疗法达到后期试验的主要目标
Vertex公司的三联CF药物达到后期试验的主要目标
Reuters · 02-06
Vertex公司的三联CF药物达到后期试验的主要目标
海韵发布限定版电源:Vertex峰睿系列樱花主题
IT 商业新闻网 · 02-03
海韵发布限定版电源:Vertex峰睿系列樱花主题
Vertex Pharmaceuticals Inc 预计每股收益 4.10 美元 - 财报前瞻
Reuters · 02-03
Vertex Pharmaceuticals Inc 预计每股收益 4.10 美元 - 财报前瞻
BUZZ-伯恩斯坦将 Vertex Pharma 的评级下调至 "市场表现 "后,该公司股价下跌
Reuters · 02-03
BUZZ-伯恩斯坦将 Vertex Pharma 的评级下调至 "市场表现 "后,该公司股价下跌
二十年来首款!福泰制药非阿片类急性镇痛新药III期研究成功
医药魔方 · 02-01
二十年来首款!福泰制药非阿片类急性镇痛新药III期研究成功
美国研究综述-先进微设备公司、HCA 医疗保健公司、Vertex 制药公司
Reuters · 01-31
美国研究综述-先进微设备公司、HCA 医疗保健公司、Vertex 制药公司
加载更多
公司概况
公司名称:
福泰制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品:KALYDECO和INCIVEK。
发行价格:
--
{"stockData":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰制药","latestPrice":418.71,"timestamp":1711654529019,"preClose":417.32,"halted":0,"volume":638760,"delay":0,"floatShares":257390616,"shares":258307816,"eps":13.89,"marketStatus":"交易中","marketStatusCode":2,"change":1.39,"latestTime":"03-28 15:35:30 EDT","open":419.48,"high":420.67,"low":415.06,"amount":267529385.1864,"amplitude":0.013443,"askPrice":418.84,"askSize":74,"bidPrice":418.66,"bidSize":140,"shortable":3,"etf":0,"ttmEps":13.89,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1711656000000},"adr":0,"adjPreClose":417.32,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":419.01,"preClose":417.32,"latestTime":"09:28 EDT","volume":468,"amount":195569.00063999998,"timestamp":1711632483064},"postHourTrading":{"tag":"盘后","latestPrice":417.32,"preClose":417.32,"latestTime":"19:36 EDT","volume":46371,"amount":19351553.1458,"timestamp":1711582616832},"volumeRatio":0.790004},"requestUrl":"/m/hq/s/VRTX","defaultTab":"news","newsList":[{"id":"2422691757","title":"回到街头:Web3数字时尚嘉年华,五大亮点燃爆香港","url":"https://stock-news.laohu8.com/highlight/detail?id=2422691757","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2422691757?lang=zh_cn&edition=full","pubTime":"2024-03-26 19:26","pubTimestamp":1711452368,"startTime":"0","endTime":"0","summary":"随着Web3世界的不断发展,我们的生活方式正在经历前所未有的变革。","market":"us","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6602b88cbde0b33a753dc7da","is_publish_highlight":false,"gpt_icon":0},{"id":"2417794800","title":"Vertex, Inc.2023财年实现净利润-13.09百万美元,同比减少6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417794800","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417794800?lang=zh_cn&edition=full","pubTime":"2024-03-08 00:24","pubTimestamp":1709828660,"startTime":"0","endTime":"0","summary":"12月31日,Vertex, Inc.公布财报,公告显示公司2023财年净利润为-13.09百万美元,同比减少6.42%;其中营业收入为5.72亿美元,同比增加16.26%,每股基本收益为-0.09美元。从资产负债表来看,Vertex, Inc.总负债5.07亿美元,其中短期债务6.29百万美元,资产负债比为1.50,流动比率为0.60。机构评级:截至2023年12月31日,当前有10家机构对Vertex, Inc.目标价做出预测,其中目标均价为37.80美元,其中最低目标价为34.00美元,最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080024238760fd76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080024238760fd76&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416144857","title":"Vertex, Inc.盘中异动 早盘股价大跌5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416144857","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416144857?lang=zh_cn&edition=full","pubTime":"2024-03-04 22:31","pubTimestamp":1709562667,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日22时31分,Vertex, Inc.股票出现波动,股价急速下挫5.99%。截至发稿,该股报31.54美元/股,成交量2.3913万股,换手率0.02%,振幅0.00%。Vertex, Inc.股票所在的软件服务行业中,整体跌幅为0.12%。Vertex, Inc.公司简介:Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案,涵盖收入、销售、消费者使用、增值和工资等各个税种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042231077a4950dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042231077a4950dd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415854035","title":"Vertex, Inc.盘中异动 早盘急速上涨29.92%报33.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415854035","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415854035?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:31","pubTimestamp":1709217114,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时31分,Vertex, Inc.股票出现波动,股价急速拉升29.92%。截至发稿,该股报33.00美元/股,成交量10.977万股,换手率0.07%,振幅8.69%。Vertex, Inc.股票所在的软件服务行业中,整体涨幅为0.28%。其相关个股中,Verb Technology Company Inc C/Wts 09/04/2024 、Versus Systems Inc C/Wts 15/01/2025、Vertex, Inc.涨幅较大,讯鸟软件、Soundhound Ai, Inc.、Datchat, Inc.较为活跃,换手率分别为7.16%、3.42%、3.07%,振幅较大的相关个股有Liveperson, Inc.、Presto Automation, Inc.、Apptech Payments Corp.,振幅分别为13.95%、10.49%、9.65%。Vertex, Inc.公司简介:Vertex Inc是一家提供税务技术和服务的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292231558af0bda7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292231558af0bda7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415753053","title":"BUZZ-Vertex Energy 因第四季度亏损跌至三年来最低点","url":"https://stock-news.laohu8.com/highlight/detail?id=2415753053","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415753053?lang=zh_cn&edition=full","pubTime":"2024-02-28 23:16","pubTimestamp":1709133379,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) (更新) 2月28日 - ** 炼油商顶点能源 股价下跌多达30%,至1.17美元的近三年低点** 受燃料毛利率和吞吐量下降的影响,该公司第四季度亏损 (link),去年同期为盈利 ** 第四季度净亏损 84 美分/小时,去年同期盈利 7 美分/小时** VTNR 公布第四季度常规燃料炼油厂吞吐量为每天 67,083 桶(bpd),去年同期为每天 77,964 桶 ** 包括本交易日的跌幅在内,该股今年累计下跌 65","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414872724","title":"Vertex Inc 预计每股收益 11 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414872724","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414872724?lang=zh_cn&edition=full","pubTime":"2024-02-27 21:41","pubTimestamp":1709041311,"startTime":"0","endTime":"0","summary":" * Vertex公司 将于2月29日公布截至2023年12月31日的业绩报告,预计该公司的季度收入将有所增长。* LSEG 分析师对 Vertex Inc 的平均预期为每股收益 11 美分。* 华尔街对 Vertex Inc 的 12 个月目标价中位数为 29.50 美元,高于其最新收盘价 25.19 美元。2月27日 - 该公司在2023年11月9日发布的截至12月31日的业绩指引中,未计利息、税项、折旧及摊销前的利润为1.45亿美元至2950万美元。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414883904","title":"Vertex Energy Inc 预计每股亏损 14 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414883904","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414883904?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:55","pubTimestamp":1708962911,"startTime":"0","endTime":"0","summary":"* 根据LSEG的数据,7位分析师的平均预期显示,这家总部位于德克萨斯州休斯顿的公司的营收预计将从去年同期的8.7629亿美元下降16.3%,至7.33067亿美元。) * LSEG 分析师对顶点能源公司的平均预期是每股亏损 14 美分。* 华尔街对顶点能源公司 12 个月目标价的中位数为 4.00 美元,高于上一次收盘价 1.66 美元。2月26日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413759544","title":"分析-2023 年美国新药价格同比上涨 35","url":"https://stock-news.laohu8.com/highlight/detail?id=2413759544","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413759544?lang=zh_cn&edition=full","pubTime":"2024-02-23 19:00","pubTimestamp":1708686011,"startTime":"0","endTime":"0","summary":" Deena Beasley 路透社2月23日 - 路透社的一项分析发现,制药公司去年推出的美国新药价格比2022年高出35%,这在一定程度上反映了该行业对肌肉萎缩症等罕见疾病昂贵疗法的追捧。根据路透社对47种药品的分析,2023年新药 ,年上市价格中位数为30万美元,高于一年前的22.2万美元 。路透社分析了 FDA 去年批准的 55 种新型药物,高于 2022 年的 37 种。根据美国政府的数据,在截至 12 月的 12 个月中,处方药价格的通胀率为 3.3%,与总体通胀率基本持平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413048785","title":"Vertex Protocol——有望成为永续合约DEX龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2413048785","media":"PentaLab","top":-1,"share":"https://www.laohu8.com/m/news/2413048785?lang=zh_cn&edition=full","pubTime":"2024-02-23 12:43","pubTimestamp":1708663399,"startTime":"0","endTime":"0","summary":"即将上线V2版本将为用户提供更多的长尾资产,长期有望成为龙头。","market":"other","thumbnail":"data:image/png;base64,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","type":0,"news_type":0,"thumbnails":["data:image/png;base64,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"],"rights":{"source":"jinse_stock","url":"https://www.jinse.cn/news/blockchain/3675685.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.jinse.cn/news/blockchain/3675685.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2413842082","title":"Google Cloud宣布推出Gemma 可于Vertex AI上使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2413842082","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2413842082?lang=zh_cn&edition=full","pubTime":"2024-02-22 08:56","pubTimestamp":1708563360,"startTime":"0","endTime":"0","summary":"继上周推出Gemini 1.5 Pro后,Google宣布发表全新开放式模型系列Gemma,目前两项模型已开放予Google Cloud用户在Vertex AI平台上使用Gemma采用与Gemini模型相同的研究、技术和基础架构组件,效能远超其他同级开放式模型。Google目前正推出Gemma 2B和Gemma 7B两种不同规模的模型。Gemma现时支援Google Cloud开发人员常用的工具,包括Colab和Kaggle Notebooks,以及JAX、PyTorch、Keras 3.0和Hugging Face Transformers等框架,而Gemma模型亦可以在手提电脑、工作站或Google Cloud上运行。Google又宣布与NVIDIA合作,优化Gemma在NVIDIA GPU上的效能。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190522122833052_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190522122833052_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1327935/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2413427483","title":"BUZZ-CRISPR Therapeutics 因季度利润向好而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2413427483","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413427483?lang=zh_cn&edition=full","pubTime":"2024-02-21 23:34","pubTimestamp":1708529677,"startTime":"0","endTime":"0","summary":" (更新) 2月21日 - ** 瑞士基因编辑公司CRISPR Therapeutics在美国上市的股票 上涨2.6%,报80.8美元。** 第四季度营收为 2.012 亿美元,预计为1.316 亿美元 - LSEG** CRISPR和VertexPharmaceuticals公司的 基因疗法Casgevy 预计将于今年年初在美国 上市,用于治疗两种不同的、已获批准的遗传性血液疾病。** 券商TD Cowen预计, Casgevy在整个2024年的销售额将远低于共识,称主要 意见领袖预计 ,由于各种限制,商业化将是一个挑战。** 截至上次收盘,该公司在美国上市的股票在过去12个月中上涨了54.7%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409440292","title":"福泰制药2023财年实现净利润36.20亿美元,同比增加8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409440292","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409440292?lang=zh_cn&edition=full","pubTime":"2024-02-06 16:21","pubTimestamp":1707207673,"startTime":"0","endTime":"0","summary":"12月31日,福泰制药公布财报,公告显示公司2023财年净利润为36.20亿美元,同比增加8.97%;其中营业收入为98.69亿美元,同比增加12.81%,每股基本收益为14.05美元。从资产负债表来看,福泰制药总负债51.50亿美元,其中短期债务--,资产负债比为4.42,流动比率为3.99。机构评级:截至2023年12月31日,当前有26家机构对福泰制药目标价做出预测,其中目标均价为449.58美元,其中最低目标价为325.00美元,最高目标价为559.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402061621178773b5e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402061621178773b5e8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409482444","title":"美国研究综述-空气化工产品公司 , Hubspot 和麦当劳","url":"https://stock-news.laohu8.com/highlight/detail?id=2409482444","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409482444?lang=zh_cn&edition=full","pubTime":"2024-02-06 15:31","pubTimestamp":1707204662,"startTime":"0","endTime":"0","summary":" 路透2月6日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括空气化工产品公司、Hubspot 和麦当劳。要闻 * 空气化工产品公司 :摩根大通将目标价从295美元下调至270美元 * Hubspot Inc :杰富瑞将目标价从620美元上调至695美元 * 麦当劳 :BTIG将其目标价从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409639534","title":"更新版 1-Vertex公司的三联CF疗法达到后期试验的主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2409639534","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409639534?lang=zh_cn&edition=full","pubTime":"2024-02-06 05:57","pubTimestamp":1707170277,"startTime":"0","endTime":"0","summary":" 路透2月5日 - Vertex制药公司 周一表示,该公司的试验性三联囊性纤维化联合疗法 在12岁及以上患者中进行的试验达到了所有后期研究目标。这种名为vanza triple的每日一次的治疗方法达到了两项为期52周的试验的主要目标,在肺功能方面与该公司最畅销的CF药物Trikafta相比没有劣势。根据美国 CF 基金会的数据,CF 是一种遗传性疾病,会对肺部、消化系统和其他器官造成严重损害,估计全球 94 个国家有 105,000 人受到影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409450547","title":"Vertex公司的三联CF药物达到后期试验的主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2409450547","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409450547?lang=zh_cn&edition=full","pubTime":"2024-02-06 05:13","pubTimestamp":1707167607,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透2月5日 - Vertex Pharmaceuticals 实验性三联囊性纤维化联合疗法(CF) 周一表示,在对12岁及以上患者进行测试时,该公司达到了所有后期研究目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408018932","title":"海韵发布限定版电源:Vertex峰睿系列樱花主题","url":"https://stock-news.laohu8.com/highlight/detail?id=2408018932","media":"IT 商业新闻网","top":-1,"share":"https://www.laohu8.com/m/news/2408018932?lang=zh_cn&edition=full","pubTime":"2024-02-03 14:44","pubTimestamp":1706942671,"startTime":"0","endTime":"0","summary":"海韵推出的Vertex SAKURA电源采用传统樱花美学设计,以白色为底色,搭配粉色樱花纹铭刻,展现出独特的美感和浪漫氛围。...","market":"us","thumbnail":"http://www.itxinwen.com/uploadfile/2024/0203/thumb_205_0_20240203024539986.png","type":0,"news_type":0,"thumbnails":["http://www.itxinwen.com/uploadfile/2024/0203/thumb_205_0_20240203024539986.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.itxinwen.com/diannao/20240203/144856.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2408683919","title":"Vertex Pharmaceuticals Inc 预计每股收益 4.10 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2408683919","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408683919?lang=zh_cn&edition=full","pubTime":"2024-02-03 06:13","pubTimestamp":1706911990,"startTime":"0","endTime":"0","summary":" * Vertex Pharmaceuticals Inc 将于2月5日公布截至2023年12月31日的季度财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,24位分析师的平均预期显示,这家总部位于波士顿马萨诸塞州的公司的营收预计将从去年同期的23亿美元增长9.2%,达到25.13亿美元。* LSEG 分析师对 Vertex Pharmaceuticals Inc 的平均预期为每股收益 4.10 美元。* 华尔街对 Vertex Pharmaceuticals Inc 的 12 个月目标价中位数为 446.00 美元,高于其上次收盘价 433.87 美元。2月2日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408293903","title":"BUZZ-伯恩斯坦将 Vertex Pharma 的评级下调至 \"市场表现 \"后,该公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2408293903","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408293903?lang=zh_cn&edition=full","pubTime":"2024-02-03 01:04","pubTimestamp":1706893494,"startTime":"0","endTime":"0","summary":" 2月2日 - ** Vertex Pharmaceuticals 股价下跌 1.64% 至 426.77 美元** 券商伯恩斯坦将其股票评级从 \"跑赢大盘 \"下调至 \"跑输大盘\",理由是2024财年的增长动力 \"越来越少\"。** 表示对 VX-264 持 \"悲观态度\",也不指望 VX-880 这两种治疗 1 型糖尿病的实验性细胞疗法能带来 \"积极的惊喜\"。** 包括本交易日的走势在内,该公司股票在过去 12 个月中上涨了约 41","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408514772","title":"二十年来首款!福泰制药非阿片类急性镇痛新药III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2408514772","media":"医药魔方","top":-1,"share":"https://www.laohu8.com/m/news/2408514772?lang=zh_cn&edition=full","pubTime":"2024-02-01 07:47","pubTimestamp":1706744823,"startTime":"0","endTime":"0","summary":"1月30日,Vertex Pharmaceuticals公布了选择性NaV1.8抑制剂VX-548治疗中至重度急性疼痛的III期项目的积极结果。该III期项目包括3项III期研究。不过,104和105研究均未达到VX-548在SPID48方面优效于双酒石酸氢可酮/对乙酰氨基酚的关键次要终点。在107研究中,通过患者整体评估衡量治疗效果,83.2%的患者将VX-548评为治疗疼痛良好、非常好或优秀。在所有III期研究中,VX-548均表现出了良好的安全性和耐受性。VX-548组不良事件发生率低于安慰剂组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402010756548761d3ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402010756548761d3ef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407303937","title":"美国研究综述-先进微设备公司、HCA 医疗保健公司、Vertex 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2407303937","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2407303937?lang=zh_cn&edition=full","pubTime":"2024-01-31 15:16","pubTimestamp":1706685400,"startTime":"0","endTime":"0","summary":" 路透1月31日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 AMD、HCA Healthcare 和 Vertex Pharmaceuticals。要闻 * AMD Inc :杰富瑞将目标价从130美元上调至200美元 * Commvault Systems Inc :D.A. Davidson将目标价从85美元上调至115美元 * HCA Healthcare Inc :加拿大皇家银行将目标价从 308 美元上调至 322 美元 * NVR Inc :摩根大通将目标价从7430美元上调至8015美元 * Vertex Pharmaceuticals Inc :贝尔德将其评级下调至 \"跑输大市\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vrtx.com","stockEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":-0.0373},{"period":"3month","weight":0.0197},{"period":"6month","weight":0.2001},{"period":"1year","weight":0.3322},{"period":"ytd","weight":0.0256}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0975},{"period":"6month","weight":0.2238},{"period":"1year","weight":0.3225},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品:KALYDECO和INCIVEK。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.030934},{"month":2,"riseRate":0.424242,"avgChangeRate":-0.001228},{"month":3,"riseRate":0.424242,"avgChangeRate":-0.02059},{"month":4,"riseRate":0.625,"avgChangeRate":0.019528},{"month":5,"riseRate":0.5625,"avgChangeRate":0.081844},{"month":6,"riseRate":0.53125,"avgChangeRate":0.029055},{"month":7,"riseRate":0.4375,"avgChangeRate":-0.00753},{"month":8,"riseRate":0.636364,"avgChangeRate":0.053489},{"month":9,"riseRate":0.484848,"avgChangeRate":0.033856},{"month":10,"riseRate":0.515152,"avgChangeRate":-0.002427},{"month":11,"riseRate":0.484848,"avgChangeRate":-0.02156},{"month":12,"riseRate":0.666667,"avgChangeRate":0.078782}],"exchange":"NASDAQ","name":"福泰制药","nameEN":"Vertex Pharmaceuticals"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福泰制药,VRTX,福泰制药股票,福泰制药股票老虎,福泰制药股票老虎国际,福泰制药行情,福泰制药股票行情,福泰制药股价,福泰制药股市,福泰制药股票价格,福泰制药股票交易,福泰制药股票购买,福泰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}